Original Publication Date: 1 May, 2015
Publication / Source: Biomarkers in Medicine
Authors: Georgios D Lianos, Christina D Bali, Christos Katsios & Dimitrios H Roukos
Despite advances in traditional research and identification of important single genes such as CDH1, personalized treatment of gastric cancer is still in its infancy. In this editorial, we summarize the potential and challenges of comprehensive high-throughput analyses, including whole-genome sequencing (WGS) and microarrays-based gene expression profiling in clinical samples. Such a revolutionary strategy can lead to the discovery of next-generation biomarkers for gastric cancer.